Thank you, Mr. Chair.
Is Dr. Njoo still with us? Yes.
Dr. Njoo, just to perhaps mix it up a bit and change the theme, I'm just wondering what, to your mind, are some of the infectious disease priorities that may have suffered as a result of our necessary focus on the pandemic over the last two years. Also, how is the agency looking to address some of the backlog of work in some priority areas of infectious disease?